SAHPRA releases results of investigation following recall of Benylin Paediatric syrup: No traces of diethylene glycol

Loading player...
GUEST – Deon Poovan, Senior Manager: Inspectorate and Regulatory Compliance at SAHPRA

On 13 April 2024, the South African Health Products Regulatory Authority (SAHPRA) initiated a precautionary recall of two batches of Benylin Paediatric Syrup (batch numbers 329303 and 329304), in response to reported high levels of diethylene glycol in an alert by the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC). The recall was implemented as a precaution to protect lives while SAHPRA investigated the reported high levels of diethylene glycol, we get an update on the outcomes of these investigations.
6 Jun 2024 2PM English South Africa Business News · Investing

Other recent episodes

Bitcoin at the Fed’s Crossroads

Bitcoin briefly touched a 12‑week high before pulling back—but with spot ETFs seeing some of their strongest inflows of the cycle, the market is shifting fast. Rob Price, CIO of Sound Money Capital, explains whether Bitcoin is still trading like a high‑beta macro asset or evolving into true sound money.
27 Apr 1PM 17 min

Oil’s Hidden Risks & Gold’s War Paradox

Oil is stuck near $90–95, but portfolio manager John Hasslet says the market is being held up by physical bottlenecks, not real fundamentals. He also unpacks why gold is falling during a major war and how inflation expectations are overpowering safe‑haven demand.
27 Apr 1PM 13 min

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min